Tag Archives: Long-Term

Flower One and CannAmerica Brands Enter Long-Term Licensing Agreement to Meet Demand for Cannabis Edibles in Nevada

Feb. 14, 2019 /CNW/ - Flower One Holdings Inc. ("Flower One" or the "Company") (CSE: FONE) (OTCQB: FLOOF) is pleased to announce a new long-term licensing agreement and brand partnership with CannAmerica Brands Corp. ("CannAmerica Brands") (CSE: CANA) (OTCQB: CNNXF) for cannabis-product fulfillment in Nevada.

INSYS Therapeutics Presents New Clinical Data from Long-Term Safety Study of CBD Oral Solution in Refractory Pediatric Epilepsy

Pharmaceutical-grade cannabidiol (CBD) oral solution made by INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, was generally well-tolerated—even at high doses—as an investigational treatment for refractory pediatric epilepsy